Our Therapies

The first and only FDA-approved
treatment for Demodex blepharitis

Biography

Wendy Yarno

Lead Independent Director

Wendy has more than 35 years of experience in the biopharmaceutical industry as a public company director and product commercialization leader, including 26 years at Merck & Co. Inc.

While at Merck, Wendy held positions of increasing seniority, most recently as Chief Marketing Officer. In that position, she led a global organization charged with all aspects of commercialization of pharmaceuticals in more than 20 therapeutic areas. She also served as General Manager, Cardiovascular/Metabolic US Business Unit, and as Merck's Senior Vice President of Human Resources. Earlier in her career, she was Vice President of the Women's Health Care franchise for Johnson & Johnson's Ortho-McNeil Pharmaceutical subsidiary.

Wendy has served on the boards of several public and private biotechnology and medical device companies, including St. Jude Medical, Medivation, Alder Biopharmaceuticals, Aratana Therapeutics, MyoKardia and Global Blood Therapeutics. She has served on the Tarsus Board of Directors since 2021 and currently serves as Lead Director and Chair of our Compensation Committee and Commercial Committee. She also serves on the boards of Ideaya Biosciences, Inovio Pharmaceuticals and Iovance Biotherapeutics. Wendy received a BS in business administration from Portland State University and an MBA from Temple University, Fox School of Business.